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INTRODUCTION  
Sarcomas are rare malignant soft tissue tumours. 
This case report outlines a pilot diagnosed with a 
pleomorphic sarcoma, his management and 
discusses aeromedical considerations for return to 
flying duties. Review of the literature shows a paucity 
of published data of sarcomas in aviators, and 
concomitant recommendation for return to flying 
duties, requiring sound medical reasoning for 
aeromedical decision making.  
CASE REPORT 
A 45 year old pilot presented to his Aviation Medical 
Doctor with a non-tender mass in his left medial 
thigh, first noticed two weeks earlier. There was no 
history of trauma. The patient was otherwise well 
with no systemic features and no noted weight loss.  
His aircrew medical had been performed just a few 
weeks earlier, which confirmed him medically fit for 
restricted flying duties in aircraft not equipped with 
an ejection system. The patient had undergone 
successful C5/6 cervical arthroplasty in early 2014 
(RAAF MEC J11 A2, restriction 6-5).  
Ultrasound and MRI were performed on the mass 
which showed a large encapsulated heterogeneous 
lesion in the adductor magnus of the left thigh, 
measuring 12.6cm x 9.2cm  x 9.5 cm in size.  
Histology from FNA gave the diagnosis of a 
pleomorphic sarcoma, with considerable necrosis 
and presence of lipoblasts, with possible diagnosis 
of pleomorphic liposacroma or dedifferentiated 
liposarcoma with a pleopmorphic liposarcoma like 
high-grade component. PET scan, CT chest and MRI 
brain showed no evidence of metastatic disease.  
The patient underwent 6 weeks of radiotherapy, 
followed by 6 weeks of recovery prior to surgical 
removal of the sarcoma.  Surgery was performed 
successfully, with complete removal of the adductor 
magnus of the left thigh, with noted wide excision  
 
ABOUT THE AUTHOR 
Katrina Franke is SMO 1EHS RAAF Amberley 
CORRESPONDENCE 
katrina.franke@defence.gov.au 
 
 
margins of the tumour. An abdominal muscle 
rotation flap was used to fill the soft tissue defect. 
Histological analysis of excised tumour was 
consistent with FNA findings. Of note, a fibrous 
pseudocapsule encased the tumour. There was no 
node involvement or metastases. Grading was 
considered FNCLCC grade 3 from FNA histology, as 
surgical specimen was difficult to interpret due to 
extensive post radiotherapy necrosis. 
Histopathology from excised tumour did not 
however show features of pleomorphic liposarcoma.  
ABSTRACT 
Sarcomas are rare malignant soft tissue tumours. 
This case report outlines a 45 year old pilot, 
presenting with a non-tender mass in his left 
medial thigh, subsequently diagnosed with a 
pleomorphic sarcoma. His management 
consisted of radiotherapy and surgical 
removal.  Grading was considered FNCLCC grade 
3 and there were no metastases.  Surgery was 
followed by a structured rehabilitation 
program.  The paper discusses aeromedical 
considerations for return to flying duties, 
regarding the natural history of the condition and 
recurrence risk as well as the operational 
mitigations to flight incapacitation risk. 
Postoperative recovery was largely uncomplicated 
and the member returned to ground duties roughly 8 
weeks post surgery. The member underwent a 
structured rehabilitation program, to regain range of 
motion, strength and endurance. There was some 
post operative left thigh lymphoedema, but this was  
managed well with a support stocking, self massage, 
exercise and weight loss. Most recent review shows 
excellent control of thigh swelling. The member did 
require left inguinal and femoral hernia repairs 7 
months post tumour removal, and he has recovered 
well from this.  
The member is now 13 months post surgery. He has 
been discharged from physio. He has returned to full 
active lifestyle, performing non flying duties, and 
consistently engaging in exercise – running, cycling, 
swimming and weights. He has passed his RAAF PFT 
2.4km run and push up component. Routine 
surveillance of chest X-ray and clinical review has 
found no recurrence of the sarcoma.   
 
 
 
 
DISCUSSION 
Sarcomas are a rare group of malignant tumours of 
mesenchymal origin. They comprise less than 1% of 
all adult malignancies (1) and approximately 80% of 
sarcomas originate from soft tissue, with the 
remainder from bone. There are about 11,930 new 
cases of soft tissue sarcomas diagnosed in the USA 
yearly, with 4870 deaths (2).  
There are more than 100 different histologic types of 
soft tissue sarcomas, of which liposarcoma is one of 
the more common types. Liposarcomas arise from 
precursors of adipocytes and are most commonly 
found in the extremities; particularly the thigh, where 
they commonly arise deep in the muscle mass; and 
the retroperitoneum.  
Sarcomas are thought to arise de novo and not from 
a preexisting benign lesion (UTD). In the majority of 
cases, there is no defined etiology, however some 
predisposing factors have been suggested, including 
exposure to radiation.  
It is well documented that aircrew is exposed to 
higher doses of ionizing radiation than that received 
by non aviator members of the general population 
(3). This is primarily from galactic cosmic radiation. 
Non ionizing radiation exposure is also increased by 
way of electronic and magnetic fields generated by 
the aircraft, and potentially by aircraft  instruments 
such as radars. Further comment on potential 
radiation exposure is outside the scope of this case 
study.   
Recurrent disease after treatment of sarcomas can 
be local or metastatic disease, predominantly 
through haematogenous spread to the lung. 
Pleomorphic liposarcomas are associated with a 
high rate of metastases commonly metastasizing to 
lung, and less commonly to the liver (4). Soft tissue 
sarcomas rarely metastasize to skin, soft tissue 
other than original site, bone, liver and brain (5).  
The most important prognostic factor in patients 
with soft tissue sarcomas is pathological stage at 
time of diagnosis. The TNM system is the most 
commonly used in staging soft tissue sarcomas. 
Histologic grade and tumour size are also very 
important in predicting prognosis and are 
independent of stage, as are anatomic site of tumour, 
patient age and histologic subtype.  The most 
commonly used nomogram for estimating prognosis 
for a patient with sarcoma is from the Memorial 
Sloan-Kettering Cancer Centre (MSKCC) (6), 
developed by Dalal et al (7).  
AEROMEDICAL CONSIDERATIONS 
The patient in this case study is a highly experienced 
military pilot with ~3,500 hours on Hawk, Tornado 
and F-111 aircraft. The patient underwent single 
level cervical arthroplasty and following this, was  
 
 
 
deemed unfit for ejection seat aircraft. He was 
waiting for conversion course to KC-30 prior to 
diagnosis of his sarcoma.   
Aeromedical considerations for return to flying 
duties include risk of recurrence, risk of sudden 
incapacitation, possible side effect of treatment 
impacting flying duties, ability to safely control the 
aircraft and the ability to egress rapidly in an 
emergency, and functionality/ potential alteration in 
risk to the member in the aviation environment.  
Risk of Recurrence 
Using the MSKCC nomogram, the member has a 
calculated likelihood of survival at 5 years of 61% and 
36% at 12 years.  This is an all age, all case risk 
calculation. Positive factors in this case are young 
age at diagnosis, clear excision margins, 
circumscribed tumour and no node involvement of 
metastases. Negative factors are tumour size >5cm, 
tumour deep to superficial fascia and Grade 3 
histology on FNA. The rate of recurrence significantly 
decreases around two years post diagnosis  (8). 
Risk of Sudden Incapacitation 
Sarcoma typically metastasizes to lung. It is not 
known to  metastasize to brain. Regular lung 
surveillance via chest Xray is likely to detect any 
metastases prior to any symptoms. Hence, sudden 
incapacitation should be considered as rare, and 
mitigated by radiological surveillance.  The member 
will be trained on the KC-30, which is a multi-pilot 
aircraft, further negating the risk.  
Treatment Side Effects 
The patient has no significant side effects from 
radiation. There has been an excellent recovery post 
surgery. He will however avoid sit-ups due to his 
abdominal flap.  
Medical Surveillance 
The recommended medical surveillance from the 
treating team was 4 monthly CXR and clinical review 
up to 2 years, then 6 monthly CXR and clinical review. 
Yearly PET scans were requested by The RAAF 
Institute of Aviation Medicine for higher sensitivity 
screening for metastases.   
Aircraft Control / Egress 
The member has demonstrated full aircraft control in 
the simulator  and no issues rapidly egressing the 
airframe in a simulated emergency.  
Aircraft Environment 
Transport aircraft cabin environment, including 
potential decompression, hypoxia, and smoke and 
fumes are not expected to affect the member beyond 
other aircrew members, or adversely impact on 
recurrence of his disease. It is anticipated that the 
member be considered MECJ23 with restrictions as 
follows: 
  
 
1-9 exempt physical fitness testing, exempt sit-up 
component  
4-2 requires access to medical logistics support, 
spectacles 
4-3 requires periodic access to specialist care 
4-4 requires pre-deployment medical officer check 
SPEC A2 
6-1 to wear (as required) and carry a spare pair of 
spectacles when flying, reading spectacles 
6-5 medically fit for restricted flying duties in aircraft 
not equipped with an ejection system 
6-6 medically fit for restricted flying duties as pilot, 
with a pilot who has no employment restrictions 
CONCLUSIONS 
This case study is an interesting case of a highly 
experienced pilot with a rare tumour which has been 
managed well, with an excellent outcome to date.  
Limited studies and cases are currently in the 
literature of similar cases to help in the complexities 
of aeromedical decision making. Although there is a 
known risk of recurrence, the decreased risk 
following two years and beyond, combined with rare 
chance of sudden risk of incapacitation and likely 
diagnosis of potential recurrence through regular 
surveillance mitigates flight safety risk. 
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